Nordea Investment Management
GTHX

Nordea Investment Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Nordea Investment Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-397,746
Closed -$3.13M – 994
2022
Q1 		$3.13M Buy
397,746
+5,636
+1% +$53.4K ﹤0.01% 653
2021
Q4 		$4.12M Sell
392,110
-4,512
-1% -$57.5K ﹤0.01% 617
2021
Q3 		$5.45M Buy
396,622
+207,307
+110% +$3.38M 0.01% 587
2021
Q2 		$4.15M Buy
+189,315
New +$4.21M 0.01% 626

Other funds holding GTHX

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nordea Investment Management's GTHX Position: Q2 2022 in Review

Nordea Investment Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2022, closing a stake of 397,746 shares — an estimated $3.13M sold.

Nordea Investment Management first reported a position in GTHX in Q2 2021 and held it in 4 quarters. The position peaked at $5.45M in Q3 2021. 98 funds tracked by Wall St. Rank hold GTHX as of Q2 2022.

  • Nordea Investment Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Nordea Investment Management sold 397,746 G1 Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $3.13M.
  • Nordea Investment Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Nordea Investment Management's G1 Therapeutics, Inc. Common Stock position peaked at $5.45M in Q3 2021.
  • 98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Nordea Investment Management's 13F filing for Q2 2022, filed 9 Aug 2022.